Design Therapeutics Inc
(NAS:DSGN)
$
5.32
0.47 (9.61%)
Market Cap: 303.49 Mil
Enterprise Value: 18.56 Mil
PE Ratio: 0
PB Ratio: 1.16
GF Score: 41/100 Design Therapeutics Inc (DSGN) Transcripts
- Q4 2023 Design Therapeutics Inc Earnings Call TranscriptMar 19, 2024$2.59 (+2.78%)Earnings
- Design Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 15, 2023
- Design Therapeutics Inc at Jefferies Cell and Genetic Medicine Summit TranscriptSep 29, 2022
- Design Therapeutics Inc at Wedbush PacGrow Healthcare Conference (Virtual) TranscriptAug 10, 2022
- 1